CBRS
Bearish signalScored 2026-10-27 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
Research, not advice.
À propos
Cerebras Systems Inc.
- Nom
- Cerebras Systems Inc.
- Secteur
- Technology
- Industrie
- Semiconductors
- Bourse
- NASDAQ
- Capitalisation
- $25.8B
- Employés
- 708
- PDG
- Andrew D. Feldman
- Site web
- https://www.cerebras.ai
- Marché
- AMDBZAICRWVNVDAPENGSMCI
Cerebras Systems Inc. is a leading innovator in artificial intelligence infrastructure. The company develops and manufactures an advanced AI compute platform, integrating proprietary hardware systems and software. This platform is delivered in rack-mountable units, suitable for deployment in data centers, scaling all the way up to supercomputer-level capabilities. At its core is the groundbreaking Wafer-Scale Engine (WSE), a unique chip that encompasses an entire silicon wafer. This innovation is specifically engineered to deliver superior performance and speed compared to conventional GPUs, addressing the intensive computational demands of inference, Generative AI, and a broad spectrum of other AI applications. Cerebras serves a diverse clientele, including leading hyperscalers, advanced foundation model laboratories, AI-native and digital-first businesses, large enterprises, and key players in Sovereign AI initiatives. With operations spanning the United States, Europe, the Middle East, Africa, and other international markets, Cerebras maintains a significant global footprint. The company was established in 2015 and is headquartered in Sunnyvale, California.
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
VENTE TOTALE: 301 644 titres (~60 100 374,42 $ US)
- Insiders
- Feldman Andrew D.
- Total bought
-
—
Avg buy (VWAP, 90d window) —
- Total sold
-
$30,664,888
Avg sell (VWAP, 90d window) $210.56 vs last close $108.37 (-48.5%)
Total sold sums Form 4 code S in this window. Codes F, M, A and G are left out.
$9,945,324 of that total is under a Rule 10b5-1 plan. It is shown here and left out of the score.
- Last activity
- 2026-09-04
- Liquidity
- Liquid $1,140,483,046/day · 20d vol
- Last synced
-
2026-10-27 04:43:11
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-29 | Komin Robert Patrick Jr. | Sell · S · 10b5-1 | 3,000 | $194.92 | $584,760 | Form 4 |
| 2026-09-29 | Mallick Dhiraj | Sell · S · 10b5-1 | 41,278 | $209.33 | $8,640,724 | Form 4 |
| 2026-09-28 | Patel Yagnesh | Sell · S · 10b5-1 | 1,320 | $204.50 | $269,940 | Form 4 |
| 2026-09-25 | Lie Sean | Sell · S · 10b5-1 | 2,200 | $204.50 | $449,900 | Form 4 |
| 2026-09-04 | Feldman Andrew D. | Sell · S | 100 | $216.62 | $21,662 | Form 4 |
| 2026-09-04 | Lie Sean | Sell · S | 53,460 | $210.16 | $11,235,154 | Form 4 |
| 2026-08-21 | Feldman Andrew D. | Sell · S | 6 | $210.21 | $1,261 | Form 4 |
| 2026-08-21 | Lie Sean | Sell · S | 16,293 | $210.01 | $3,421,693 | Form 4 |
| 2026-08-20 | Lie Sean | Sell · S | 24,652 | $212.64 | $5,242,001 | Form 4 |
| 2026-08-18 | Lie Sean | Sell · S | 771 | $240.01 | $185,048 | Form 4 |
| 2026-08-18 | Mallick Dhiraj | Sell · S | 1,417 | $240.01 | $340,094 | Form 4 |
| 2026-08-18 | Patel Yagnesh | Sell · S | 166 | $240.01 | $39,842 | Form 4 |
| 2026-08-18 | Feldman Andrew D. | Sell · S | 970 | $240.01 | $232,810 | Form 4 |
Sales marked 10b5-1 are scheduled in advance and don't count toward the Quorum score. Les ventes marquées 10b5-1 sont planifiées à l'avance et ne pèsent pas dans le score Quorum.
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Signal
Bearish signalScored 2026-10-27 Drivers: trend, fundamentals. Moteurs : tendance, fondamentaux.
CBRS combines fragile fundamentals (negative operating cash flow, negative equity, disconnected valuation multiples) with a weak catalyst score of 35, undermined by massive insider selling of $60M+ which sharply…
The first sentence of the analysis written for CBRS on 2026-10-27 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Timing Pulls against a bullish reading. Close is more than 0.5 ATR under stored support
- Financial indicators Unavailable or mixed. Current ratio 2.15 · operating margin -28% — readings disagree
Suggested stop 93.56, 1.5 ATR under the last close(13.7% under the last close). Reward/risk to the next stored resistance is 6.41. Research, not advice. Not an order.
Recent news
- 2026-10-23 Cerebras: I Waited For This Entry Point Cerebras Systems Inc. has fallen 69% from its $386 peak, while Q2 core revenue still grew 103% year over year. RPO reached $25.4 billion, cash exceeded $8.6 billion, and management expects 2027 core revenue to more than triple. AMD integration could increase throughput around 5x, but customer deployment and real revenue conversion remain the key proof points.
- 2026-10-23 AAOI vs. CBRS: Which AI Infrastructure Stock Has an Edge Now? Applied Optoelectronics holds an edge over Cerebras in the AI infrastructure race, backed by surging optical demand, capacity expansion, and a stronger earnings outlook.
- 2026-10-23 3 Magnificent AI Chip Stocks That Could Help Set You Up for Life Nvidia''s chips run every major AI model, and even its decade-old Volta chips are still in demand. Broadcom co-designs custom AI chips that are in increasing demand from the biggest AI labs.
- 2026-10-22 Harvard''s Endowment Has 75% of Its Stock Portfolio in 5 AI Stocks. Genius Move or Dangerous Trap? A look at Harvard Management Company''s latest public filings reveals a massive concentration in tech and AI leaders such as SpaceX, TSMC, Cerebras, Amazon, and Alphabet.
- 2026-10-22 It''s Been All Downhill Since Cerebras Systems May IPO: 180% Gains Await According to This Wall Street Analyst Cerebras Systems has shed more than 60% since its splashy debut, yet Wall Street analysts keep raising their price targets.
- 2026-10-20 Cerebras Systems Announces Date of Third-Quarter 2026 Financial Results SUNNYVALE, Calif., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Cerebras Systems Inc. (NASDAQ: CBRS), maker of the world''s fastest AI infrastructure, will release third-quarter 2026 financial results, after the market closes on Thursday, November 12, 2026.
- 2026-10-19 Nasdaq Bounces Back as Chip Stocks Stabilize The Nasdaq is leading the rally today thanks to rallying semiconductor and AA stocks
- 2026-10-19 Semiconductor Sell-Off: 5 Stocks to Buy on the Dip These five stocks are worth buying during the current sell-off in the semiconductor space.
- 2026-10-18 Cerebras Systems: Beaten To A Pulp On Irrational Fears (Rating Upgrade) Cerebras Systems has collapsed in the last couple of weeks, despite robust demand and capacity constraints driving a bullish long-term growth thesis. The AI wafer-scale chip company is forecast to nearly 10x sales by 2028 due to substantial capacity growth in the next few years. The short-term market panic centers on capacity limitations and customer risks, but business fundamentals remain unchanged, and future profitability is expected.
- 2026-10-16 Should You Hold on to Cerebras Stock Despite Its 25% One-Month Dip? CBRS stock plunges 25.3% in a month, but surging AI demand, a $25.4 billion backlog, and capacity expansion support growth despite margin pressures.
Market snapshot
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.0% | 42.3% | 33.5% | 11.7% | |
| Ebit Margin | 48.0% | -165.3% | -161.3% | -721.0% | |
| Ebitda Margin | 54.8% | -161.3% | -147.9% | -672.5% | |
| Operating Profit Margin | -28.5% | -35.0% | -170.1% | -726.4% | |
| Pretax Profit Margin | 48.0% | -165.3% | -161.3% | -721.0% | |
| Continuous Operations Profit Margin | 46.6% | -165.9% | -161.5% | -721.9% | |
| Net Profit Margin | 46.6% | -165.9% | -161.5% | -721.9% | |
| Bottom Line Profit Margin | 17.2% | -167.0% | -161.5% | -721.9% | |
| Current Ratio | 2.145 | 0.875 | 3.885 | 11.613 | |
| Quick Ratio | 2.057 | 0.727 | 2.987 | 10.717 | |
| Solvency Ratio | 0.094 | -0.226 | -0.149 | -0.222 | |
| Cash Ratio | 0.975 | 0.187 | 0.636 | 1.196 | |
| Price To Earnings Ratio | 758.707 | -138.253 | -527.237 | -374.783 | |
| Price To Earnings Growth Ratio | -6.418 | -0.491 | 18.234 | 0.000 | |
| Forward Price To Earnings Growth Ratio | -6.418 | -0.491 | 18.234 | 0.000 | |
| Price To Earnings Diluted Ratio | 758.707 | -138.253 | -527.237 | -374.783 | |
| Price To Earnings Diluted Growth Ratio | -6.418 | -0.491 | 18.234 | 0.000 | |
| Price To Book Ratio | -115.701 | -69.251 | -119.778 | -143.569 | |
| Price To Sales Ratio | 131.279 | 230.666 | 850.238 | 2,719.491 | |
| Price To Free Cash Flow Ratio | -170.451 | 156.230 | -782.414 | -382.873 | |
| Price To Operating Cash Flow Ratio | -6,661.805 | 148.129 | -847.730 | -407.240 | |
| Debt To Assets Ratio | 0.113 | 0.037 | 0.002 | 0.005 | |
| Debt To Equity Ratio | -0.452 | -0.042 | -0.001 | -0.003 | |
| Debt To Capital Ratio | -0.826 | -0.044 | -0.001 | -0.003 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | -4.020 | -1.151 | -0.403 | -0.604 | |
| Working Capital Turnover Ratio | 1.508 | 58.079 | 0.405 | 0.000 | |
| Operating Cash Flow Ratio | -0.014 | 0.384 | -1.445 | -7.541 | |
| Operating Cash Flow Sales Ratio | -0.020 | 1.557 | -1.003 | -6.678 | |
| Free Cash Flow Operating Cash Flow Ratio | 39.083 | 0.948 | 1.083 | 1.064 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | -0.038 | 11.112 | -141.030 | -126.658 | |
| Capital Expenditure Coverage Ratio | -0.026 | 19.286 | -11.979 | -15.713 | |
| Dividend Paid And Capex Coverage Ratio | -0.026 | 19.286 | -11.979 | -15.713 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | 375.582 | -224.666 | -904.501 | -636.148 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 39.0% | ▼-3.2% | ▲7.4% |
| Ebit Margin | 48.0% | ▲213.3% | ▲297.9% |
| Ebitda Margin | 54.8% | ▲216.1% | ▲286.5% |
| Operating Profit Margin | -28.5% | ▲6.5% | ▲211.5% |
| Pretax Profit Margin | 48.0% | ▲213.3% | ▲297.9% |
| Continuous Operations Profit Margin | 46.6% | ▲212.6% | ▲297.3% |
| Net Profit Margin | 46.6% | ▲212.6% | ▲297.3% |
| Bottom Line Profit Margin | 17.2% | ▲184.2% | ▲275.5% |
| Current Ratio | 2.145 | ▲1.271 | ▼-2.484 |
| Quick Ratio | 2.057 | ▲1.330 | ▼-2.065 |
| Solvency Ratio | 0.094 | ▲0.320 | ▲0.219 |
| Cash Ratio | 0.975 | ▲0.788 | ▲0.227 |
| Price To Earnings Ratio | 758.707 | ▲896.961 | ▲829.099 |
| Price To Earnings Growth Ratio | -6.418 | ▼-5.926 | ▼-9.249 |
| Forward Price To Earnings Growth Ratio | -6.418 | ▼-5.926 | ▼-9.249 |
| Price To Earnings Diluted Ratio | 758.707 | ▲896.961 | ▲829.099 |
| Price To Earnings Diluted Growth Ratio | -6.418 | ▼-5.926 | ▼-9.249 |
| Price To Book Ratio | -115.701 | ▼-46.450 | ▼-3.627 |
| Price To Sales Ratio | 131.279 | ▼-99.386 | ▼-851.639 |
| Price To Free Cash Flow Ratio | -170.451 | ▼-326.680 | ▲124.426 |
| Price To Operating Cash Flow Ratio | -6661.805 | ▼-6809.934 | ▼-4719.644 |
| Debt To Assets Ratio | 0.113 | ▲0.076 | ▲0.073 |
| Debt To Equity Ratio | -0.453 | ▼-0.410 | ▼-0.328 |
| Debt To Capital Ratio | -0.826 | ▼-0.782 | ▼-0.608 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | -4.020 | ▼-2.869 | ▼-2.475 |
| Working Capital Turnover Ratio | 1.508 | ▼-56.572 | ▼-13.490 |
| Operating Cash Flow Ratio | -0.014 | ▼-0.398 | ▲2.140 |
| Operating Cash Flow Sales Ratio | -0.020 | ▼-1.577 | ▲1.516 |
| Free Cash Flow Operating Cash Flow Ratio | 39.084 | ▲38.135 | ▲28.539 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | -0.038 | ▼-11.151 | ▲64.115 |
| Capital Expenditure Coverage Ratio | -0.026 | ▼-19.313 | ▲2.082 |
| Dividend Paid And Capex Coverage Ratio | -0.026 | ▼-19.313 | ▲2.082 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | 375.582 | ▲600.249 | ▲723.016 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Market cap | $105.35B | $105.35B | $105.35B | $105.35B | |
| Enterprise value | $104.91B | $105.17B | $105.32B | $105.33B | |
| EV / Sales | 205.72x | 362.36x | 1337.50x | 4278.38x | |
| EV / Op. cash flow | -10439.25x | 232.70x | -1333.55x | -640.68x | |
| EV / Free cash flow | -267.10x | 245.42x | -1230.81x | -602.35x | |
| EV / EBITDA | 375.58x | -224.67x | -904.50x | -636.15x | |
| Net debt / EBITDA | -1.57x | 0.38x | 0.29x | 0.15x | |
| Current ratio | 2.15x | 0.88x | 3.88x | 11.61x | |
| Income quality | -0.04x | -0.94x | 0.62x | 0.93x | |
| Graham net-net | -$8 | -$7 | -$3 | -$2 | |
| Tax burden | 97.1% | 100.4% | 100.1% | 100.1% | |
| Interest burden | 100.0% | 100.0% | 100.0% | 100.0% | |
| Working capital | $824.1M | -$147.7M | $157.7M | $231.4M | |
| Invested capital | $1.51B | -$67.9M | $170.7M | $259.4M | |
| Return on assets | 10.2% | -43.3% | -56.4% | -63.1% | |
| Operating ROA | -8.4% | -15.2% | -52.8% | 0.0% | |
| Return on tangible assets | 10.2% | -43.3% | -56.4% | -63.1% | |
| Return on equity | -41.1% | 49.8% | 22.7% | 38.1% | |
| Return on invested capital | -8.5% | 195.1% | -78.2% | -68.7% | |
| Return on capital employed | -9.0% | 155.4% | -78.4% | -68.9% | |
| Earnings yield | 0.4% | -0.7% | -0.2% | -0.3% | |
| Free cash flow yield | -0.6% | 0.6% | -0.1% | -0.3% | |
| Capex / Op. cash flow | -3808.3% | 5.2% | -8.3% | -6.4% | |
| Capex / Depreciation | 1110.9% | 203.1% | 62.3% | 87.6% | |
| Capex / Sales | 75.0% | 8.1% | 8.4% | 42.5% | |
| SG&A / Sales | 19.9% | 22.7% | 25.7% | 106.8% | |
| R&D / Sales | 47.7% | 54.5% | 177.9% | 631.3% | |
| Stock comp / Sales | 9.8% | 20.2% | 33.8% | 68.5% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 53d | 189d | 31d | 75d | |
| Days payables outstanding | 57d | 56d | 102d | 85d | |
| Operating cycle | 128d | 570d | 373d | 403d | |
| Cash conversion cycle | 71d | 514d | 271d | 319d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Change over 5 years
Employee count
No employee-count data synced.